Cited by 1,063Genetic factors in colorectal cancerColorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Open access

Vilar, Eduardo, Gruber, Stephen B.·2010·Nature Reviews Clinical Oncology

DOI 10.1038/nrclinonc.2009.237PMC PMC3427139

Open this paper in CoChat — free account

Abstract

Microsatellite instability (MSI) is the molecular fingerprint of a deficient mismatch repair system. Approximately 15% of colorectal cancers (CRC) display MSI owing either to epigenetic silencing of MLH1 or a germline mutation in one of the mismatch repair genes MLH1, MSH2, MSH6 or PMS2. Methods to detect MSI are well established and routinely incorporated into clinical practice. A clinical and molecular profile of MSI tumors has been described, leading to the concept of an MSI phenotype in CRC. Studies have confirmed that MSI tumors have a better prognosis than microsatellite stable CRC, but MSI cancers do not necessarily have the same response to the chemotherapeutic strategies used to treat microsatellite stable tumors. Specifically, stage II MSI tumors might not benefit from 5-fluorouracil-based adjuvant chemotherapy regimens. New data suggest possible advantages of irinotecan-based regimens, but these findings require further clarification. Characterization of the molecular basis of MSI in CRC is underway and initial results show that mutations in genes encoding kinases and candidate genes with microsatellite tracts are over-represented in MSI tumors. Transcriptome expression profiles of MSI tumors and systems biology approaches are providing the opportunity to develop targeted therapeutics for MSI CRC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrclinonc.2009.237

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G. D., & Schaid, D. J. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,131
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,876

Flagged first, then by citations

Show all 100 references

Sorted by citations

Items 101–200 of 1,000

Cancer-associated fibroblasts undergoing neoadjuvant chemotherapy suppress rectal cancer revealed by single-cell and spatial transcriptomics
Qin, P., Chen, H., Wang, Y., Huang, L., Huang, K., Xiao, G., Han, C., Hu, J., Lin, D., Wan, X., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101231 · Cited by 93
Artificial Intelligence for Histology-Based Detection of Microsatellite Instability and Prediction of Response to Immunotherapy in Colorectal Cancer
Hildebrand, L. A., Pierce, C., Dennis, M. J., Paracha, M., & Maoz, A. (2021) · Cancers · doi:10.3390/cancers13030391 · Cited by 91
Opportunities for immunotherapy in microsatellite instable colorectal cancer
Westdorp, H., Fennemann, F. L., Weren, R. D. A., Bisseling, T. M., Ligtenberg, M. J. L., Figdor, C. G., Schreibelt, G., Hoogerbrugge, N., Wimmers, F., & de Vries, I. J. M. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1832-7 · Cited by 88
PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer
Li, L., Feng, Q., & Wang, X. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.03.007 · Cited by 88
Algorithmic methods to infer the evolutionary trajectories in cancer progression
Caravagna, G., Graudenzi, A., Ramazzotti, D., Pamplona, R. S., Sano, L. D., Mauri, G., Moreno, V. R., Antoniotti, M., & Mishra, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1520213113 · Cited by 89
Resistance to DNA repair inhibitors in cancer
Baxter, J. S., Zatreanu, D. A., Pettitt, S. J., & Lord, C. J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13224 · Cited by 91
Marine ω-3 Polyunsaturated Fatty Acid Intake and Risk of Colorectal Cancer Characterized by Tumor-Infiltrating T Cells
Song, M., Nishihara, R., Cao, Y., Chun, E., Qian, Z. R., Mima, K., Inamura, K., Masugi, Y., Nowak, J. A., Nosho, K., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0605 · Cited by 88
Era of universal testing of microsatellite instability in colorectal cancer
Zhang, X., & Li, J. (2013) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v5.i2.12 · Cited by 86
DNA Polymerase and Mismatch Repair Exert Distinct Microsatellite Instability Signatures in Normal and Malignant Human Cells
Chung, J., Maruvka, Y. E., Sudhaman, S., Kelly, J., Haradhvala, N. J., Bianchi, V., Edwards, M., Forster, V. J., Nunes, N. M., Galati, M. A., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0790 · Cited by 91
Immune overdrive signature in colorectal tumor subset predicts poor clinical outcome
Fakih, M., Ouyang, C., Wang, C., Tu, T. Y., Gozo, M. C., Cho, M., Sy, M., Longmate, J. A., & Lee, P. P. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127046 · Cited by 84
Measuring single cell divisions in human tissues from multi-region sequencing data
Werner, B., Case, J., Williams, M. J., Chkhaidze, K., Temko, D., Fernández-Mateos, J., Cresswell, G. D., Nichol, D., Cross, W. C. H., Spiteri, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14844-6 · Cited by 87
The role of antioxidants and pro-oxidants in colon cancer
Stone, W. L., Krishnan, K., Campbell, S., & Palau, V. E. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i3.55 · Cited by 84
Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
Zaanan, A., Fléjou, J., Emile, J., Guetz, G. D., Dartigues, P., Malka, D., Lecaille, C., Validire, P., Louvet, C., Rougier, P. R., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1048 · Cited by 83
Clinicopathological characteristics of high microsatellite instability/mismatch repair-deficient colorectal cancer: A narrative review
Mei, W.-J., Mi, M., Qian, J., Xiao, N., Yuan, Y., & Ding, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1019582 · Cited by 83
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes
Wu, W., Liu, Y., Zeng, S., Han, Y., & Shen, H. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01166-3 · Cited by 83
MSI phenotype and MMR alterations in familial and sporadic gastric cancer
Leite, M., Corso, G., Sousa, S., Milanezi, F., Afonso, L. P., Henrique, R., Soares, J. M., Castedo, S. M. M. J., Carneiro, F., Roviello, F., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25495 · Cited by 81
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009
Cutsem, E. V., Dicato, M. A., Arber, N., Berlin, J. D., Cervantes, A. M. R., Ciardiello, F., de Gramont, A., Díaz‐Rubio, E., Ducreux, M. P., Geva, R., et al. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq273 · Cited by 80
Diagnostic Accuracy of Immunohistochemistry for Mismatch Repair Proteins as Surrogate of Microsatellite Instability Molecular Testing in Endometrial Cancer
Raffone, A., Travaglino, A., Cerbone, M., Gencarelli, A., Mollo, A., Insabato, L., & Zullo, F. (2020) · Pathology & Oncology Research · doi:10.1007/s12253-020-00811-5 · Cited by 80
Role of microsatellite instability in the management of colorectal cancers
Buecher, B., Cacheux, W., Rouleau, É., Dieumegard, B., Mitry, E., & Lièvre, A. (2012) · Digestive and Liver Disease · doi:10.1016/j.dld.2012.10.006 · Cited by 79
Molecular biomarkers for an early diagnosis, effective treatment and prognosis of colorectal cancer: Current updates
Mahasneh, A., Al-Shaheri, F., & Jamal, E. (2017) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2017.05.005 · Cited by 78
Hereditary cancer syndromes
Имянитов, Е. Н., Kuligina, E. S., Соколенко, А. П., Suspitsin, E. N., Yanus, G. A., Iyevleva, A. G., Ivantsov, A. O., & Алексахина, С. Н. (2023) · World Journal of Clinical Oncology · doi:10.5306/wjco.v14.i2.40 · Cited by 82
Aberrations in DNA repair pathways in cancer and therapeutic significances
Motegi, A., Masutani, M., Yoshioka, K., & Bessho, T. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.02.005 · Cited by 76
An SH3PX1-Dependent Endocytosis-Autophagy Network Restrains Intestinal Stem Cell Proliferation by Counteracting EGFR-ERK Signaling
Zhang, P., Holowatyj, A. N., Roy, T., Pronovost, S. M., Marchetti, M., Liu, H., Ulrich, C. M., & Edgar, B. A. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.03.029 · Cited by 76
Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial
Tikidzhieva, A., Benner, A., Michel, S., Formentini, A., Link, K. H., Dippold, W. G., Doeberitz, M. V. K., Kornmann, M., & Kloor, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.53 · Cited by 76
Interrelationship between microsatellite instability and microRNA in gastrointestinal cancer
Yamamoto, H. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i22.2745 · Cited by 76
Clinical Significance and Prognostic Relevance of Microsatellite Instability in Sporadic Colorectal Cancer Patients
Copija, A., Waniczek, D., Witkoś, A., Walkiewicz, K. W., & Nowakowska‐Zajdel, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010107 · Cited by 76
The Prevalence and Prognosis of Microsatellite Instability-High/Mismatch Repair-Deficient Colorectal Adenocarcinomas in the United States
Gutierrez, C., Ogino, S., Meyerhardt, J. A., & Iorgulescu, J. B. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00179 · Cited by 74
Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
Aran, A., Garrigós, L., Curigliano, G., Cortés, J., & Martı́, M. (2022) · Cancers · doi:10.3390/cancers14071771 · Cited by 72
A new strategy for immunotherapy of microsatellite‐stable (MSS) ‐type advanced colorectal cancer: Multi‐pathway combination therapy with PD ‐1/ PD‐L1 inhibitors
Cai, L., Chen, A., & Tang, D. (2024) · Immunology · doi:10.1111/imm.13785 · Cited by 73
The molecular biology of colorectal carcinoma and its implications: A review
Harrison, S., & Benziger, H. (2011) · The Surgeon · doi:10.1016/j.surge.2011.01.011 · Cited by 71
The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy
Ahn, S., Ansari, A. A., Kim, J., Kim, D., Chun, S., Kim, J., Kim, T. W., Park, I. J., Yu, C. S., & Jang, S. J. (2016) · Oncotarget · doi:10.18632/oncotarget.11862 · Cited by 72
Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence
Xu, Z., Li, W., Dong, X., Chen, Y., Zhang, D., Wang, J. G., Zhou, L., & He, G. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.119686 · Cited by 69
Implications of mismatch repair-deficient status on management of early stage colorectal cancer.
Kawakami, H., Zaanan, A., & Sinicrope, F. A. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.065 · Cited by 69
Accelerating anticancer drug development — opportunities and trade-offs
Nass, S. J., Rothenberg, M. L., Pentz, R. D., Hricak, H., Abernethy, A. P., Anderson, K. C., Gee, A. W., Harvey, R. D., Piantadosi, S., Bertagnolli, M. M., et al. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0102-3 · Cited by 70
Germline Variants Impact Somatic Events during Tumorigenesis
Ramroop, J. R., Gerber, M. M., & Toland, A. E. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.04.005 · Cited by 68
Molecular Analysis of Colorectal Tumors within a Diverse Patient Cohort at a Single Institution
Sylvester, B. E., Huo, D., Khramtsov, A., Zhang, J., Smalling, R. V., Olugbile, S. O., Polite, B. N., & Olopade, O. I. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1397 · Cited by 68
Multi-omics Approach Reveals Distinct Differences in Left- and Right-Sided Colon Cancer
Hu, W., Yang, Y., Li, X., Huang, M., Xu, F., Ge, W., Zhang, S., & Zheng, S. S. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0483 · Cited by 68
Accurate Pan-Cancer Molecular Diagnosis of Microsatellite Instability by Single-Molecule Molecular Inversion Probe Capture and High-Throughput Sequencing
Waalkes, A., Smith, N. T., Penewit, K. M., Hempelmann, J. A., Konnick, E. Q., Hause, R. J., Pritchard, C. C., & Salipante, S. J. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.285981 · Cited by 69
MicroRNAs and Inflammation in the Pathogenesis and Progression of Colon Cancer
Okayama, H., Schetter, A. J., & Harris, C. C. (2012) · Digestive Diseases · doi:10.1159/000341882 · Cited by 67
Molecular Pathways and Cellular Metabolism in Colorectal Cancer
Hagland, H. R., Berg, M., Jolma, I. W., Carlsen, A., & Søreide, K. (2013) · Digestive Surgery · doi:10.1159/000347166 · Cited by 67
Comprehensive analysis of potential immunotherapy genomic biomarkers in 1000 Chinese patients with cancer
Zang, Y., Dai, C., Xu, X., Cai, X., Wang, G., Wei, J., Wu, A., Sun, W., Jiao, S., & Xu, Q. (2019) · Cancer Medicine · doi:10.1002/cam4.2381 · Cited by 65
The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis
Tu, J., Park, S.-H., Yu, W., Zhang, S., Wu, L., Carmon, K. S., & Liu, Q. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-54931-3 · Cited by 67
Novel Biomarkers of Gastric Cancer: Current Research and Future Perspectives
Sato, Y., Okamoto, K., Kawano, Y., Kasai, A., Kawaguchi, T., Sagawa, T., Sogabe, M., Miyamoto, H., & Takayama, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12144646 · Cited by 70
Clinical Aspects of Microsatellite Instability Testing in Colorectal Cancer
Zeinalian, M., Chaleshtori, M. H., Salehi, R., & Emami, M. H. (2018) · Advanced Biomedical Research · doi:10.4103/abr.abr_185_16 · Cited by 65
Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology
Cohen, S. A., Pritchard, C. C., & Jarvik, G. P. (2019) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-083118-015406 · Cited by 64
Prognostic and Predictive Molecular Biomarkers in Advanced Colorectal Cancer
Martelli, V., Pastorino, A., & Sobrero, A. F. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108239 · Cited by 63
Biomarkers for Stratification in Colorectal Cancer: MicroRNAs
Fadaka, A. O., Pretorius, A., & Klein, A. (2019) · Cancer Control · doi:10.1177/1073274819862784 · Cited by 63
Nivolumab plus relatlimab in patients with previously treated microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study
Overman, M. J., Gelsomino, F., Aglietta, M., Wong, M. K., Mirón, M. L. L., Leonard, G., Alfonso, P. G., Hill, A. G., Gracián, A. C., Cutsem, E. V., et al. (2024) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-008689 · Cited by 63
A robust genomic signature for the detection of colorectal cancer patients with microsatellite instability phenotype and high mutation frequency
Tian, S., Roepman, P., Popovici, V. C., Michaut, M., Majewski, I. J., Salazar, R., Santos, C., Rosenberg, R., Nitsche, U., Mesker, W. E., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4092 · Cited by 64
Elderly patients with colon cancer have unique tumor characteristics and poor survival
Patel, S. S., Nelson, R. A., Sanchez, J., Lee, W., Uyeno, L., García‐Aguilar, J., Hurria, A., & Kim, J. (2012) · Cancer · doi:10.1002/cncr.27753 · Cited by 64
Microsatellite instability in colorectal cancer: from molecular oncogenic mechanisms to clinical implications
Zaanan, A., Meunier, K., Sangar, F., Fléjou, J., & Praz, F. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0024-x · Cited by 66
P5 eHealth: An Agenda for the Health Technologies of the Future
Pravettoni, G., & Triberti, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-27994-3 · Cited by 63
Multi-omics pan-cancer study of cuproptosis core gene FDX1 and its role in kidney renal clear cell carcinoma
Xu, J., Hu, Z., Cao, H., Zhang, H., Luo, P., Zhang, J., Wang, X., Cheng, Q., & Li, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.981764 · Cited by 62
Interobserver variability in the evaluation of mismatch repair protein immunostaining
Klarskov, L. L., Ladelund, S., Holck, S., Rønlund, K., Lindebjerg, J., Elebro, J., Halvarsson, B., von Salomé, J., Bernstein, I., & Nilbert, M. C. (2010) · Human Pathology · doi:10.1016/j.humpath.2010.03.003 · Cited by 61
MRN (MRE11-RAD50-NBS1) Complex in Human Cancer and Prognostic Implications in Colorectal Cancer
Situ, Y., Chung, L., Lee, C. S., & Ho, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040816 · Cited by 61
Comprehensive genome- and transcriptome-wide analyses of mutations associated with microsatellite instability in Korean gastric cancersPreprint
Yoon, K., Lee, S., Han, T., Moon, S. Y., Yun, S. M., Kong, S., Jho, S., Choe, J., Yu, J., Lee, H.-J., et al. (2013) · Genome Research · doi:10.1101/gr.145706.112 · Cited by 63
Molecular targets and targeted therapeutics in endometrial cancer
Weigelt, B., & Banerjee, S. N. (2012) · Current Opinion in Oncology · doi:10.1097/cco.0b013e328354e585 · Cited by 60
DNA demethylation in normal colon tissue predicts predisposition to multiple cancers
Kamiyama, H., Suzuki, K., Maeda, T., Koizumi, K., Miyaki, Y., Okada, S., Kawamura, Y., Samuelsson, J. K., Alonso, S., Konishi, F., et al. (2012) · Oncogene · doi:10.1038/onc.2011.652 · Cited by 60
PRKDC : new biomarker and drug target for checkpoint blockade immunotherapy
Tan, K. T., Yeh, C., Chang, Y., Cheng, J.-H., Fang, W., Yeh, Y., Wang, Y., Hsu, D. S., Wu, C., Lai, J., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000485 · Cited by 59
Clinicopathologic and Molecular Profiles of Microsatellite Unstable Barrett Esophagus-associated Adenocarcinoma
Farris, A. B., Demicco, E. G., Le, L. P., Finberg, K. E., Miller, J., Mandal, R. V., Fukuoka, J., Cohen, C., Gaissert, H. A., Zukerberg, L. R., et al. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31820f18a2 · Cited by 59
MSIplus for Integrated Colorectal Cancer Molecular Testing by Next-Generation Sequencing
Hempelmann, J. A., Scroggins, S. M., Pritchard, C. C., & Salipante, S. J. (2015) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2015.05.008 · Cited by 59
Circulating tumor cells in colorectal cancer patients
Torino, F., Bonmassar, E., Bonmassar, L., Vecchis, L. D., Barnabei, A., Zuppi, C., Capoluongo, E., & Aquino, A. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.12.007 · Cited by 57
Low Level of Microsatellite Instability Correlates with Poor Clinical Prognosis in Stage II Colorectal Cancer Patients
Mojarad, E. N., Kashfi, S. M. H., Mirtalebi, H., Taleghani, M. Y., Azimzadeh, P., Savabkar, S., Pourhoseingholi, M. A., Jalaeikhoo, H., Aghdaei, H. A., Kuppen, P. J. K., et al. (2016) · Journal of Oncology · doi:10.1155/2016/2196703 · Cited by 57
Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies
Alvi, M. A., Loughrey, M. B., Dunne, P. D., McQuaid, S., Turkington, R. C., Fuchs, M.-A., McGready, C., Bingham, V., Pang, B., Moore, W., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.168 · Cited by 58
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes
Cereda, M., Gambardella, G., Benedetti, L. G., Iannelli, F., Patel, D., Basso, G., Guerra, R. F., Mourikis, T. P., Puccio, I., Sinha, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12072 · Cited by 58
Challenges and solutions in patient treatment strategies for stage II colon cancer
Fotheringham, S. A., Mozolowski, G., Murray, E. M. A., & Kerr, D. J. (2019) · Gastroenterology report · doi:10.1093/gastro/goz006 · Cited by 56
Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer
Salita, T., Rustam, Y. H., Mouradov, D., Sieber, O. M., & Reid, G. E. (2022) · Cancers · doi:10.3390/cancers14153714 · Cited by 55
Predictive Biomarkers and Resistance Mechanisms of Checkpoint Inhibitors in Malignant Solid Tumors
Pavelescu, L. A., Enache, R. M., Roşu, O. A., Profir, M., Creţoiu, S. M., & Gașpar, B. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179659 · Cited by 59
Genomic and Immunological Tumor Profiling Identifies Targetable Pathways and Extensive CD8+/PDL1+ Immune Infiltration in Inflammatory Breast Cancer Tumors
Hamm, C. A., Moran, D. M., Rao, K., Trusk, P. B., Pry, K. J., Sausen, M., Jones, S., Velculescu, V. E., Cristofanilli, M., & Bacus, S. S. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0353 · Cited by 55
A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment
Wen, J., Mao, X., Cheng, Q., Liu, Z., & Liu, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-01933-9 · Cited by 59
KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy
Yamane, L., Scapulatempo‐Neto, C., Alvarenga, L. M., de Oliveira, C. Z., Berardinelli, G. N., Almodova, E. D. C., CUNHA, T. R., Fava, G., Colaiacovo, W., Melani, A. G. F., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3338 · Cited by 54
Impact of Molecular Alterations and Targeted Therapy in Appendiceal Adenocarcinomas
Raghav, K. P. S., Shetty, A. V., Kazmi, S. M. A., Zhang, N., Morris, J. S., Taggart, M. W., Fournier, K. F., Royal, R. E., Mansfield, P. F., Eng, C., et al. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0186 · Cited by 54
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Gharib, E., & Robichaud, G. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179463 · Cited by 55
High-level Microsatellite Instability in Appendiceal Carcinomas
Taggart, M. W., Galbincea, J. M., Mansfield, P. F., Fournier, K. F., Royal, R. E., Overman, M. J., Rashid, A., & Abraham, S. C. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318282649b · Cited by 53
Pattern of clinically relevant mutations in consecutive series of Russian colorectal cancer patients
Yanus, G. A., Belyaeva, A. V., Ivantsov, A. O., Kuligina, E. S., Suspitsin, E. N., Mitiushkina, N. V., Алексахина, С. Н., Iyevleva, A. G., Zaitseva, O. A., Yatsuk, O. S., et al. (2013) · Medical Oncology · doi:10.1007/s12032-013-0686-5 · Cited by 53
Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer
Nakanishi, R., Harada, J., Tuul, M., Zhao, Y., Ando, K., Saeki, H., Oki, E., Ohga, T., Kitao, H., Kakeji, Y., et al. (2012) · International Journal of Clinical Oncology · doi:10.1007/s10147-012-0501-x · Cited by 53
Combination of T-Cell Bispecific Antibodies With PD-L1 Checkpoint Inhibition Elicits Superior Anti-Tumor Activity
Sam, J., Colombetti, S., Fauti, T., Roller, A., Biehl, M., Fahrni, L., Nicolini, V., Perro, M., Nayak, T. K., Bommer, E., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.575737 · Cited by 54
Systematic review of machine learning-based radiomics approach for predicting microsatellite instability status in colorectal cancer
Wang, Q., Xu, J., Wang, A., Chen, Y., Wang, T., Chen, D., Zhang, J., & Brismar, T. B. (2023) · La radiologia medica · doi:10.1007/s11547-023-01593-x · Cited by 52
Association between mutations of critical pathway genes and survival outcomes according to the tumor location in colorectal cancer
Lee, D., Han, S., Cha, Y., Bae, J. M., Kim, H., Lyu, J., Han, H., Kim, H., Jang, H. S., Bang, D., et al. (2017) · Cancer · doi:10.1002/cncr.30760 · Cited by 52
Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer
Abdel‐Wahab, R., Yap, T. A., Madison, R. W., Pant, S., Cooke, M. B., Wang, K., Zhao, H., Bekaii‐Saab, T., Karatas, E., Kwong, L. N., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77939-6 · Cited by 51
MASS SPECTROMETRY‐BASED PERSONALIZED DRUG THERAPY
Cui, J., Wang, L., Tan, Z., Zhou, H., Zhan, X., & Yin, J. (2020) · Mass Spectrometry Reviews · doi:10.1002/mas.21620 · Cited by 51
The prognostic role of microsatellite instability, codon-specificKRAS, andBRAFmutations in colon cancer
Lin, C., Lin, J.-K., Lin, T.-C., Chen, W.-S., Yang, S.-H., Wang, H.-S., Lan, Y., Jiang, J., Yang, M., & Chang, S. (2014) · Journal of Surgical Oncology · doi:10.1002/jso.23675 · Cited by 51
Current and future molecular diagnostics in colorectal cancer and colorectal adenoma
Tsang, H. F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i14.3847 · Cited by 50
Genomic Instability Causes HGF Gene Activation in Colon Cancer Cells, Promoting Their Resistance to Necroptosis
Seneviratne, D. S., Ma, J., Tan, X., Kwon, Y.-K., Muhammad, E., Melhem, M. F., DeFrances, M. C., & Zarnegar, R. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.09.019 · Cited by 51
Assessing colorectal cancer mismatch repair status in the modern era: a survey of current practices and re-evaluation of the role of microsatellite instability testing
Hissong, E. M., Crowe, E. P., Yantiss, R. K., & Chen, Y. (2018) · Modern Pathology · doi:10.1038/s41379-018-0094-7 · Cited by 50
Prevalent Pseudoprogression and Pseudoresidue in Patients With Rectal Cancer Treated With Neoadjuvant Immune Checkpoint Inhibitors
Xie, Y., Lin, J., Zhang, N., Wang, X., Wang, P., Peng, S., Li, J., Wu, Y., Huang, Y., Zhuang, Z., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.7071 · Cited by 49
Long-read sequencing reveals the landscape of aberrant alternative splicing and novel therapeutic target in colorectal cancer
Sun, Q., Ye, H., He, J., Wang, J., Ma, X., Ning, Q., Zhao, Q., Jin, Q., Yang, L., Li, S., et al. (2023) · Genome Medicine · doi:10.1186/s13073-023-01226-y · Cited by 52
Optimization of a pentaplex panel for MSI analysis without control DNA in a Brazilian population: correlation with ancestry markers
Campanella, N. C., Berardinelli, G. N., Scapulatempo‐Neto, C., Viana, D. D. A., Palmero, E. I., Pereira, R., & Reis, R. M. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2013.256 · Cited by 50
Genomics and epigenomics of colorectal cancer
Schweiger, M. R., Hussong, M., Röhr, C., & Lehrach, H. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1206 · Cited by 52
Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy
Turksma, A. W., Coupé, V. M. H., Shamier, M. C., Lam, K., de Weger, V. A., Beliën, J. A. M., van den Eertwegh, A. J. M., Meijer, G. A., Meijer, C. J. L. M., & Hooijberg, E. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2462 · Cited by 49
Genomic Alteration Characterization in Colorectal Cancer Identifies a Prognostic and Metastasis Biomarker: FAM83A|IDO1
Liu, Z., Zhang, Y., Dang, Q., Wu, K., Jiao, D., Li, Z., Sun, Z., & Han, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.632430 · Cited by 48
PARP inhibitors in cancer therapy: an update
Papeo, G., Casale, E., Montagnoli, A., & Cirla, A. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.768615 · Cited by 48
MARCO is a potential prognostic and immunotherapy biomarker
Dong, Q., Zhang, S., Zhang, H., Sun, J., Lü, J., Wang, G., & Wang, X. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109783 · Cited by 48
Association of microsatellite instability (MSI) status with the 5-year outcome and genetic ancestry in a large Brazilian cohort of colorectal cancer
Berardinelli, G. N., Durães, R. O., da Costa, A. M., Bragagnoli, A. S. C., de Oliveira, M. A., Pereira, R., Scapulatempo‐Neto, C., Guimarães, D. P., & Reis, R. M. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-022-01104-y · Cited by 47
Butyrate Inhibits Indices of Colorectal Carcinogenesis via Enhancing α‐Ketoglutarate‐Dependent DNA Demethylation of Mismatch Repair Genes
Sun, X., & Zhu, M. J. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201700932 · Cited by 46
Lynch Syndrome: Its Impact on Urothelial Carcinoma
Lindner, A. K., Schachtner, G., Tulchiner, G. A., Thurnher, M., Untergasser, G., Obrist, P., Pipp, I., Steinkohl, F., Horninger, W., Čulig, Z., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020531 · Cited by 45
Path Toward Prognostication and Prediction: An Evolving Matrix
Benson, A. B., & Hamilton, S. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8646 · Cited by 45
Distinct molecular features of colorectal cancer in Ghana
Raskin, L., Dakubo, J. C. B., Palaski, N., Greenson, J. K., & Gruber, S. B. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.07.007 · Cited by 44
Self-citation
Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSI⁃H Locally Advanced Colorectal Cancer: A Single-Center Real-World Study
Zhang, X., Yang, R., Wu, T., Cai, X., Li, G., Yu, K., Li, Y., Ding, R., Dong, C., Li, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.913483 · Cited by 44
Drug therapy for hereditary cancers
Имянитов, Е. Н., & Moiseyenko, V. M. (2011) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-9-5 · Cited by 45

Authors: Vilar, E., & Gruber, S. B.
Affiliations: University of Michigan (US)
Corresponding author: Gruber, Stephen B.
ORCID: Vilar, Eduardo
Gruber, Stephen B.
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2010-02-09
Volume: 7
Issue: 3
Pages: 153-162
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/nrclinonc.2009.237
PMC: PMC3427139
OpenAlex: W2050658928
Cited by: 1,063
References: 100
Citations by year: 2026: 57 · 2025: 100 · 2024: 116 · 2023: 114 · 2022: 99 · 2021: 81 · 2020: 75 · 2019: 65 · 2018: 66 · 2017: 46 · 2016: 34 · 2015: 47 · 2014: 44 · 2013: 44 · 2012: 28
FWCI: 4.61
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (5P30 CA 46592, 1R01CA81488, R01CA081488, P30CA046592)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords: microsatellite instability, colorectal cancer, mismatch repair deficiency, prognosis, predictive biomarkers, irinotecan, kinase mutations, targeted therapy
MeSH terms: DNA Repair, Humans, Colorectal Neoplasms, Germ-Line Mutation, DNA Repair Enzymes, Microsatellite Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks